Page values for "Mirtazapine"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Mirtazapine
brand	`String`	Remeron (US brand discontinued; generic widely available), Remeron SolTab (ODT)
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Tetracyclic antidepressants\|Tetracyclic antidepressant]] • [[:Category:Antidepressants\|Antidepressant]] • [[:Category:Sleep aids\|Sleep aid (off-label)]]
mechanism	`String`
uses	`String`	'"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"'
starting_dose	`String`	15 mg PO at bedtime, titrate to 30-45 mg/day after 1-2 weeks. '''Counterintuitive dose paradox''': lower doses (7.5-15 mg) are more sedating than higher doses because H1 antihistamine effect dominates at low dose
preparations	`String`	Tablets 7.5, 15, 30, 45 mg; orally disintegrating tablets (SolTab) 15, 30, 45 mg
fda_max	`String`	45 mg/day
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Oral
onset	`String`	Sleep effect from first dose; antidepressant effect over 1-4 weeks
duration	`String`	24 hours (HS dosing)
halflife	`String`	20-40 hours'"`UNIQ--ref-00000023-QINU`"'
bioavailability	`String`	~50% (oral; substantial first-pass)'"`UNIQ--ref-00000024-QINU`"'
pregnancy	`String`	Limited human data; some observational signals reassuring relative to other antidepressants.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed\|citation needed]]]</sup>
legal	`String`	[[USLegal:Prescription only\|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-00000025-QINU`"'